Literature DB >> 17567936

Role of alpha/beta and gamma/delta T cells in renal ischemia-reperfusion injury.

Kathrin Hochegger1, Tobias Schätz, Philipp Eller, Andrea Tagwerker, Dorothea Heininger, Gert Mayer, Alexander R Rosenkranz.   

Abstract

T cells have been implicated in the pathogenesis of renal ischemia-reperfusion injury (IRI). To date existing data about the role of the T cell receptor (Tcr) are contradictory. We hypothesize that the Tcr plays a prominent role in the late phase of renal IRI. Therefore, renal IRI was induced in alpha/beta, gamma/delta T cell-deficient and wild-type mice by clamping renal pedicles for 30 min and reperfusing for 24, 48, 72, and 120 h. Serum creatinine increased equally in all three groups 24 h after ischemia but significantly improved in Tcr-deficient animals compared with wild-type controls after 72 h. A significant reduction in renal tubular injury and infiltration of CD4+ T-cells in both Tcr-deficient mice compared with wild-type controls was detected. Infiltration of alpha/beta T cells into the kidney was reduced in gamma/delta T cell-deficient mice until 72 h after ischemia. In contrast, gamma/delta T cell infiltration was equal in wild-type and alpha/beta T cell-deficient mice, suggesting an interaction between alpha/beta and gamma/delta T cells. Data from gamma/delta T cell-deficient mice were confirmed by in vivo depletion of gamma/delta T cells in C57BL/6 mice. Whereas alpha/beta T cell-deficient mice were still protected after 120 h, gamma/delta T cell-deficient mice showed a "delayed wild-type phenotype" with a dramatic increase in kidney-infiltrating alpha/beta, Tcr-expressing CD4+ T-cells. This report provides further evidence that alpha/beta T cells are major effector cells in renal IRI, whereas gamma/delta T cells play a role as mediator cells in the first 72 h of renal IRI.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17567936     DOI: 10.1152/ajprenal.00486.2006

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  26 in total

Review 1.  Role of chemokines, innate and adaptive immunity.

Authors:  Kurt A Zimmerman; Katharina Hopp; Michal Mrug
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

Review 2.  Tissue-Resident Lymphocytes in the Kidney.

Authors:  Jan-Eric Turner; Martina Becker; Hans-Willi Mittrücker; Ulf Panzer
Journal:  J Am Soc Nephrol       Date:  2017-11-01       Impact factor: 10.121

Review 3.  Innate T cells in the intensive care unit.

Authors:  Edy Yong Kim; William M Oldham
Journal:  Mol Immunol       Date:  2018-12-13       Impact factor: 4.407

Review 4.  Immune cells in experimental acute kidney injury.

Authors:  Hye Ryoun Jang; Hamid Rabb
Journal:  Nat Rev Nephrol       Date:  2014-10-21       Impact factor: 28.314

Review 5.  Cellular pathophysiology of ischemic acute kidney injury.

Authors:  Joseph V Bonventre; Li Yang
Journal:  J Clin Invest       Date:  2011-11-01       Impact factor: 14.808

Review 6.  The role of innate immunity in donor organ procurement.

Authors:  Dianne B McKay
Journal:  Semin Immunopathol       Date:  2011-03-23       Impact factor: 9.623

Review 7.  T cells in organ ischemia reperfusion injury.

Authors:  Jianhua Rao; Ling Lu; Yuan Zhai
Journal:  Curr Opin Organ Transplant       Date:  2014-04       Impact factor: 2.640

Review 8.  The innate immune response in ischemic acute kidney injury.

Authors:  Hye Ryoun Jang; Hamid Rabb
Journal:  Clin Immunol       Date:  2008-10-14       Impact factor: 3.969

9.  Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury.

Authors:  Satoshi Kuboki; Nozomu Sakai; Johannes Tschöp; Michael J Edwards; Alex B Lentsch; Charles C Caldwell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-05       Impact factor: 4.052

10.  Mathematical Modeling of Early Cellular Innate and Adaptive Immune Responses to Ischemia/Reperfusion Injury and Solid Organ Allotransplantation.

Authors:  Judy D Day; Diana M Metes; Yoram Vodovotz
Journal:  Front Immunol       Date:  2015-09-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.